EP3452591A4 - Analyse de macromolécules au moyen du codage par acides nucléiques - Google Patents

Analyse de macromolécules au moyen du codage par acides nucléiques Download PDF

Info

Publication number
EP3452591A4
EP3452591A4 EP17793198.7A EP17793198A EP3452591A4 EP 3452591 A4 EP3452591 A4 EP 3452591A4 EP 17793198 A EP17793198 A EP 17793198A EP 3452591 A4 EP3452591 A4 EP 3452591A4
Authority
EP
European Patent Office
Prior art keywords
nucleic acid
acid encoding
analysis employing
employing nucleic
macromolecule analysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP17793198.7A
Other languages
German (de)
English (en)
Other versions
EP3452591B1 (fr
EP3452591A1 (fr
Inventor
Mark Chee
Kevin Gunderson
Michael Phillip Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encodia Inc
Original Assignee
Encodia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encodia Inc filed Critical Encodia Inc
Priority to EP23184223.8A priority Critical patent/EP4299803A3/fr
Publication of EP3452591A1 publication Critical patent/EP3452591A1/fr
Publication of EP3452591A4 publication Critical patent/EP3452591A4/fr
Application granted granted Critical
Publication of EP3452591B1 publication Critical patent/EP3452591B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6818—Sequencing of polypeptides
    • G01N33/6824—Sequencing of polypeptides involving N-terminal degradation, e.g. Edman degradation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/619—Detection means characterised by use of a special device being a video camera
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/10—Oligonucleotides as tagging agents for labelling antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Peptides Or Proteins (AREA)
EP17793198.7A 2016-05-02 2017-05-02 Analyse de macromolécules au moyen du codage par acides nucléiques Active EP3452591B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP23184223.8A EP4299803A3 (fr) 2016-05-02 2017-05-02 Analyse de macromolécules au moyen du codage par acides nucléiques

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662330841P 2016-05-02 2016-05-02
US201662339071P 2016-05-19 2016-05-19
US201662376886P 2016-08-18 2016-08-18
PCT/US2017/030702 WO2017192633A1 (fr) 2016-05-02 2017-05-02 Analyse de macromolécules au moyen du codage par acides nucléiques

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP23184223.8A Division EP4299803A3 (fr) 2016-05-02 2017-05-02 Analyse de macromolécules au moyen du codage par acides nucléiques
EP23184223.8A Division-Into EP4299803A3 (fr) 2016-05-02 2017-05-02 Analyse de macromolécules au moyen du codage par acides nucléiques

Publications (3)

Publication Number Publication Date
EP3452591A1 EP3452591A1 (fr) 2019-03-13
EP3452591A4 true EP3452591A4 (fr) 2019-12-04
EP3452591B1 EP3452591B1 (fr) 2023-08-16

Family

ID=60203299

Family Applications (2)

Application Number Title Priority Date Filing Date
EP17793198.7A Active EP3452591B1 (fr) 2016-05-02 2017-05-02 Analyse de macromolécules au moyen du codage par acides nucléiques
EP23184223.8A Pending EP4299803A3 (fr) 2016-05-02 2017-05-02 Analyse de macromolécules au moyen du codage par acides nucléiques

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP23184223.8A Pending EP4299803A3 (fr) 2016-05-02 2017-05-02 Analyse de macromolécules au moyen du codage par acides nucléiques

Country Status (12)

Country Link
US (7) US12019077B2 (fr)
EP (2) EP3452591B1 (fr)
JP (5) JP7120630B2 (fr)
KR (3) KR102379048B1 (fr)
CN (1) CN110199019B (fr)
AU (1) AU2017259794B2 (fr)
CA (1) CA3022863A1 (fr)
DK (1) DK3452591T5 (fr)
MX (1) MX2018013341A (fr)
NZ (1) NZ747941A (fr)
SG (2) SG11201809649WA (fr)
WO (1) WO2017192633A1 (fr)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3901281T3 (fi) 2015-04-10 2023-01-31 Biologisten näytteiden spatiaalisesti eroteltu moninkertainen nukleiinihappoanalyysi
US11285490B2 (en) 2015-06-26 2022-03-29 Ancera, Llc Background defocusing and clearing in ferrofluid-based capture assays
CN110199019B (zh) 2016-05-02 2024-09-10 Encodia有限公司 采用核酸编码的大分子分析
EP3488018A4 (fr) * 2016-07-22 2020-02-12 President and Fellows of Harvard College Procédés et compositions pour l'identification de protéines
US10650312B2 (en) 2016-11-16 2020-05-12 Catalog Technologies, Inc. Nucleic acid-based data storage
CA3043887A1 (fr) 2016-11-16 2018-05-24 Catalog Technologies, Inc. Stockage de donnees base sur des acides nucleiques
GB201707140D0 (en) * 2017-05-04 2017-06-21 Oxford Nanopore Tech Ltd Method
GB201715684D0 (en) * 2017-09-28 2017-11-15 Univ Gent Means and methods for single molecule peptide sequencing
US20200256862A1 (en) * 2017-10-23 2020-08-13 Massachusetts Institute Of Technology Functionalized solid support
EP3704249A4 (fr) * 2017-10-31 2021-10-27 Encodia, Inc. Kits d'analyse utilisant un codage et/ou une étiquette d'acide nucléique
WO2019089851A1 (fr) * 2017-10-31 2019-05-09 Encodia, Inc. Procédés et kits faisant appel au codage et/ou au marquage par acides nucléiques
EP3714053A4 (fr) * 2017-11-22 2021-11-24 The University of Chicago Évaluation sonde chimique-dépendante de l'activité protéique et ses utilisations
JP7364604B2 (ja) 2018-03-16 2023-10-18 カタログ テクノロジーズ， インコーポレイテッド 核酸ベースのデータ記憶のための化学的方法
JP7326778B2 (ja) * 2018-03-19 2023-08-16 株式会社リコー 核酸試料含有容器、核酸試料含有容器の製造方法、核酸試料含有容器の製造装置及び核酸試料含有容器の製造プログラム、並びに、核酸試料
AU2019301750A1 (en) * 2018-07-12 2021-01-28 Board Of Regents, The University Of Texas System Molecular neighborhood detection by oligonucleotides
CN108866046A (zh) * 2018-07-25 2018-11-23 辽宁润基生物科技有限公司 一种分离、纯化样品中外泌体和/或游离核酸的方法
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
CA3111472A1 (fr) * 2018-09-04 2020-03-12 Encodia, Inc. Analyse d'interaction de proximite
WO2020061036A1 (fr) * 2018-09-17 2020-03-26 California Institute Of Technology Détection d'associations moléculaires
US11078480B2 (en) * 2018-09-19 2021-08-03 California Institute Of Technology High-throughput identification of intermolecular interactions
US20210340192A1 (en) * 2018-10-05 2021-11-04 University Of Washington Reporter constructs for nanopore-based detection of biological activity
EP3881078A1 (fr) 2018-11-15 2021-09-22 Quantum-Si Incorporated Procédés et compositions de séquençage de protéines
EP3894587A1 (fr) 2018-12-10 2021-10-20 10X Genomics, Inc. Résolution de réseaux spatiaux par déconvolution basée sur la proximité
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
CN113474651B (zh) 2019-01-08 2024-05-17 麻省理工学院 单分子蛋白质和肽测序
EP3914706A4 (fr) * 2019-01-21 2022-12-28 Encodia, Inc. Procédés et compositions d'accélération de réactions pour l'analyse de polypeptides et utilisations associées
MX2021011726A (es) * 2019-03-26 2021-10-22 Encodia Inc Escindasas modificadas, usos de las mismas y kits relacionados.
US11427814B2 (en) 2019-03-26 2022-08-30 Encodia, Inc. Modified cleavases, uses thereof and related kits
EP3958727A4 (fr) * 2019-04-23 2023-05-03 Encodia, Inc. Procédés d'analyse spatiale de protéines et kits associés
WO2020223000A1 (fr) * 2019-04-30 2020-11-05 Encodia, Inc. Procédés de préparation d'analytes et kits associés
US20220227889A1 (en) * 2019-04-30 2022-07-21 Encodia, Inc. Methods and reagents for cleavage of the n-terminal amino acid from a polypeptide
EP3966823A1 (fr) 2019-05-09 2022-03-16 Catalog Technologies, Inc. Structures de données et opérations de recherche, de calcul et d'indexation dans une mémoire de données à base d'adn
WO2020243579A1 (fr) 2019-05-30 2020-12-03 10X Genomics, Inc. Procédés de détection de l'hétérogénéité spatiale d'un échantillon biologique
WO2020254672A1 (fr) * 2019-06-19 2020-12-24 Therycell Gmbh Caractérisation spatiale de structures cibles dans un échantillon
US11346842B2 (en) 2019-06-20 2022-05-31 Massachusetts Institute Of Technology Single molecule peptide sequencing methods
US11535842B2 (en) 2019-10-11 2022-12-27 Catalog Technologies, Inc. Nucleic acid security and authentication
WO2021086913A1 (fr) * 2019-10-28 2021-05-06 Quantum-Si Incorporated Procédés de séquençage de protéine et d'acide nucléique monocellulaires
EP4025711A2 (fr) 2019-11-08 2022-07-13 10X Genomics, Inc. Amélioration de la spécificité de la liaison d'un analyte
WO2021133842A1 (fr) 2019-12-23 2021-07-01 10X Genomics, Inc. Compositions et méthodes d'utilisation d'échantillons biologiques fixés dans des dosages basés sur des compartiments
EP4424843A3 (fr) 2019-12-23 2024-09-25 10X Genomics, Inc. Procédés d'analyse spatiale à l'aide d'une ligature à matrice d'arn
EP4073263A4 (fr) * 2020-01-07 2023-11-08 Encodia, Inc. Procédés de formation d'un complexe stable et kits associés
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US12076701B2 (en) 2020-01-31 2024-09-03 10X Genomics, Inc. Capturing oligonucleotides in spatial transcriptomics
US12110541B2 (en) 2020-02-03 2024-10-08 10X Genomics, Inc. Methods for preparing high-resolution spatial arrays
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
KR102376443B1 (ko) * 2020-02-26 2022-03-17 포항공과대학교 산학협력단 나노구조체, 나노구조체를 포함하는 바이오센서, 및 스크리닝 방법
KR102482668B1 (ko) * 2020-03-10 2022-12-29 사회복지법인 삼성생명공익재단 고유 분자 식별자의 표지 정확도를 증진하는 방법
US20240011009A1 (en) * 2020-03-24 2024-01-11 Encodia, Inc. Modified dipeptide cleavases, uses thereof and related kits
CN112280829B (zh) * 2020-04-07 2023-12-26 南方科技大学 一种试剂盒、样本标记方法、单细胞测序方法
US20230193355A1 (en) * 2020-04-16 2023-06-22 Singleron (Nanjing) Biotechnologies, Ltd. Methods and compositions for high-throughput target sequencing in single cells
CN115916999A (zh) 2020-04-22 2023-04-04 10X基因组学有限公司 用于使用靶向rna耗竭进行空间分析的方法
US11306353B2 (en) 2020-05-11 2022-04-19 Catalog Technologies, Inc. Programs and functions in DNA-based data storage
EP4143579A2 (fr) 2020-05-20 2023-03-08 Quantum-si Incorporated Procédés et compositions de séquençage de protéines
EP4414459A3 (fr) 2020-05-22 2024-09-18 10X Genomics, Inc. Mesure spatio-temporelle simultanée de l'expression génique et de l'activité cellulaire
AU2021275906A1 (en) 2020-05-22 2022-12-22 10X Genomics, Inc. Spatial analysis to detect sequence variants
WO2021242834A1 (fr) 2020-05-26 2021-12-02 10X Genomics, Inc. Procédé de réinitialisation d'un réseau
EP4025692A2 (fr) 2020-06-02 2022-07-13 10X Genomics, Inc. Procédés de banques d'acides nucléiques
US12031177B1 (en) 2020-06-04 2024-07-09 10X Genomics, Inc. Methods of enhancing spatial resolution of transcripts
WO2021252499A1 (fr) 2020-06-08 2021-12-16 10X Genomics, Inc. Méthodes de détermination de marge chirurgicale et méthodes d'utilisation associées
EP4165207B1 (fr) 2020-06-10 2024-09-25 10X Genomics, Inc. Methode pour determiner la position d'un analyte dans un echantillon biologique
EP4450639A2 (fr) 2020-06-25 2024-10-23 10X Genomics, Inc. Analyse spatiale de la méthylation de l'adn
US11981960B1 (en) 2020-07-06 2024-05-14 10X Genomics, Inc. Spatial analysis utilizing degradable hydrogels
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
WO2022015845A2 (fr) * 2020-07-14 2022-01-20 Ancera Llc Systèmes, dispositifs et méthodes d'analyse
US11981958B1 (en) 2020-08-20 2024-05-14 10X Genomics, Inc. Methods for spatial analysis using DNA capture
US20230332202A1 (en) * 2020-08-21 2023-10-19 Ancera, Inc. Systems, devices and methods for determing most probable number in biological sample analysis
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
AU2021409136A1 (en) 2020-12-21 2023-06-29 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
EP4347879A1 (fr) 2021-06-03 2024-04-10 10X Genomics, Inc. Procédés, compositions, kits et systèmes pour améliorer la capture d'analytes pour une analyse spatiale
US11521947B1 (en) * 2021-07-14 2022-12-06 Nxp Usa, Inc. Space efficient flip chip joint design
EP4196605A1 (fr) 2021-09-01 2023-06-21 10X Genomics, Inc. Procédés, compositions et kits pour bloquer une sonde de capture sur un réseau spatial
AU2022416435A1 (en) * 2021-12-14 2024-07-04 Glyphic Biotechnologies, Inc. Single-molecule peptide sequencing through molecular barcoding and ex-situ analysis
CN115951051B (zh) * 2022-10-18 2024-01-12 北京卓诚惠生生物科技股份有限公司 一种高灵敏度新型冠状病毒抗原胶体金检测试剂盒及其制备方法
WO2024178395A1 (fr) * 2023-02-24 2024-08-29 The Board Of Trustees Of The Leland Stanford Junior University Procédés de séquençage de polypeptides et compositions associées
CN118335197B (zh) * 2024-06-17 2024-09-24 南方科技大学 一种基于纳米孔测序芯片的dna数据存储方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009050261A1 (fr) * 2007-10-19 2009-04-23 Pronota N.V. Préparation d'échantillons pour une analyse protéomique
US20090264300A1 (en) * 2005-12-01 2009-10-22 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US20110245111A1 (en) * 2010-04-05 2011-10-06 Prognosys Biosciences, Inc. Spatially encoded biological assays

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863870A (en) 1988-03-10 1989-09-05 Bio-Affinity Systems, Inc. Method of thioacylation peptide sequencing with alcoholysis of thiazolinones
US5484735A (en) 1989-08-23 1996-01-16 Northwestern University Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated N-terminal amino acids
US5049507A (en) 1989-12-21 1991-09-17 Applied Biosystems, Inc. Method of C-terminal peptide sequencing
ES2097925T3 (es) 1991-09-18 1997-04-16 Affymax Tech Nv Metodo para sintetizar diversas colecciones de oligomeros.
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
CA2176414A1 (fr) 1995-05-18 1996-11-19 S. David Kimball Promedicaments a base de guanidine et d'amidine acylees
AU6632496A (en) 1995-08-03 1997-03-05 Rijksuniversiteit Te Leiden Cell derived antigen presenting vesicles
JP3124507B2 (ja) 1996-05-24 2001-01-15 セイコーインスツルメンツ株式会社 タンパク質あるいはペプチドのカルボキシ末端からのアミノ酸配列を決定する方法
US5900481A (en) 1996-11-06 1999-05-04 Sequenom, Inc. Bead linkers for immobilizing nucleic acids to solid supports
DE69835143T2 (de) 1997-01-21 2007-06-06 The General Hospital Corp., Boston Selektion von proteinen mittels rns-protein fusionen
US6306588B1 (en) 1997-02-07 2001-10-23 Invitrogen Corporation Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
US6465193B2 (en) 1998-12-11 2002-10-15 The Regents Of The University Of California Targeted molecular bar codes and methods for using the same
US6875851B1 (en) 1999-03-05 2005-04-05 University Of Georgia Research Foundation, Inc. Prolyl tripeptidyl peptidases nucleic acid of Porphyromonas gingivalis
AU772069B2 (en) 1999-03-23 2004-04-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Protein isolation and analysis
AU5723700A (en) 1999-05-25 2000-12-12 Praelux Incorporated Method for sequency and characterizing polymeric biomolecules using aptamers anda method for producing aptamers
DK1870417T3 (da) 1999-07-27 2012-07-16 Bristol Myers Squibb Co Peptidacceptor-ligeringsmetoder
GB9927320D0 (en) 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US7306904B2 (en) 2000-02-18 2007-12-11 Olink Ab Methods and kits for proximity probing
US6511809B2 (en) 2000-06-13 2003-01-28 E. I. Du Pont De Nemours And Company Method for the detection of an analyte by means of a nucleic acid reporter
CA2314398A1 (fr) 2000-08-10 2002-02-10 Edward Shipwash Jeux ordonnes de microechantillons et microsystemes pour l'analyse d'acides amines et le sequencage de proteines
CA2434139C (fr) 2001-01-23 2014-05-27 President And Fellows Of Harvard College Reseaux de proteines a acide nucleique programmable
US20030087232A1 (en) 2001-01-25 2003-05-08 Fred Christians Methods for screening polypeptides
WO2002102820A1 (fr) 2001-06-20 2002-12-27 Nuevolution A/S Derives nucleosidiques pour elaboration de bibliotheque combinatoire
EP1404846B1 (fr) 2001-07-06 2013-09-11 Institut Pasteur Procede permettant l'obtention de cellules possedant des proprietes nouvelles
US7169894B2 (en) 2001-11-14 2007-01-30 Mirari Biosciences, Inc. Methods and compositions for reverse translation
JP2005509444A (ja) 2001-11-23 2005-04-14 シモン・フレデリックソン 多価近接プローブにより近接プロービングするための方法およびキット
JP2006516889A (ja) 2002-10-10 2006-07-13 ダイヴァーサ コーポレイション プロテアーゼ、それをコードする核酸並びにその製造および使用方法
US20090246879A1 (en) 2002-12-20 2009-10-01 Callida Genomics Materials and Methods Relating to Nano-Tags and Nano-Brands
WO2005015239A2 (fr) 2003-08-07 2005-02-17 Cornell Research Foundation, Inc. Procede pour marquer des proteines au terminal n
US7198900B2 (en) 2003-08-29 2007-04-03 Applera Corporation Multiplex detection compositions, methods, and kits
DE602004023960D1 (de) * 2003-09-18 2009-12-17 Nuevolution As Methode zur Gewinnung struktureller Informationen kodierter Moleküle und zur Selektion von Verbindungen
US7579165B2 (en) 2003-10-16 2009-08-25 Shimadzu Corporation Methods for derivatizing protein or peptide with sulfonic acid groups
CN101864412A (zh) 2003-12-17 2010-10-20 普雷西斯药品公司 合成编码文库的方法
GB0404187D0 (en) 2004-02-25 2004-03-31 Biotransformations Ltd Binding agents
EP1730277B1 (fr) 2004-03-22 2009-10-28 Nuevolution A/S Codage par ligature utilisant des oligonucleotides motifs structuraux
CA2563168A1 (fr) 2004-04-14 2005-11-17 President And Fellows Of Harvard College Reseaux de proteines programmables par des acides nucleiques
US7393665B2 (en) 2005-02-10 2008-07-01 Population Genetics Technologies Ltd Methods and compositions for tagging and identifying polynucleotides
US20060199279A1 (en) 2005-03-07 2006-09-07 Viorica Lopez-Avila Methods for identifying post-translationally modified polypeptides
US7229769B2 (en) 2005-03-25 2007-06-12 Illumina, Inc. Compositions and methods for detecting protease activity
US7883848B2 (en) 2005-07-08 2011-02-08 Olink Ab Regulation analysis by cis reactivity, RACR
US20070020640A1 (en) 2005-07-21 2007-01-25 Mccloskey Megan L Molecular encoding of nucleic acid templates for PCR and other forms of sequence analysis
US7611834B2 (en) 2005-09-30 2009-11-03 Sandia Corporation Methods and devices for protein assays
US20070218503A1 (en) 2006-02-13 2007-09-20 Mitra Robi D Methods of polypeptide identification, and compositions therefor
DE102006015001A1 (de) 2006-03-31 2007-10-11 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren zum Nachweis und/oder zur Anreicherung von Analytproteinen und/oder Analytpeptiden aus einer komplexen Proteinmischung
WO2007127848A1 (fr) 2006-04-26 2007-11-08 University Of Louisville Research Foundation, Inc Isolation de vésicules membranaires de fluides biologiques et procédés d'utilisation
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
WO2009019215A1 (fr) 2007-08-03 2009-02-12 Dkfz Deutsches Krebsforschungszentrum Methode de diagnostic prenatal mettant en œuvre des exosomes et cd24 comme marqueur
WO2010065322A1 (fr) 2008-12-01 2010-06-10 Research Triangle Institute Identification simultanée de multitudes de polypeptides
WO2010065531A1 (fr) 2008-12-01 2010-06-10 Robi David Mitra Criblage de protéine à molécule unique
US9085798B2 (en) 2009-04-30 2015-07-21 Prognosys Biosciences, Inc. Nucleic acid constructs and methods of use
US9566335B1 (en) 2009-09-25 2017-02-14 The Governing Council Of The University Of Toronto Protein sequencing method and reagents
US9175340B2 (en) 2009-11-04 2015-11-03 President And Fellows Of Harvard College Reactivity-dependent and interaction-dependent PCR
US20110245101A1 (en) 2010-04-05 2011-10-06 Prognosys Biosciences, Inc. Co-localization affinity assays
AU2011237669B2 (en) 2010-04-06 2016-09-08 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for disease
US20130059741A1 (en) * 2010-05-13 2013-03-07 Illumina, Inc. Binding assays for markers
EP3399035B1 (fr) 2010-09-27 2021-02-17 Vipergen Procédé de préparation d'une banque enrichie
JP6219721B2 (ja) 2010-11-10 2017-10-25 エキソソーム ダイアグノスティックス インコーポレイテッド 核酸含有粒子の単離および該粒子からの核酸の抽出のための方法
GB201101621D0 (en) 2011-01-31 2011-03-16 Olink Ab Method and product
WO2012112804A1 (fr) * 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions et méthodes de marquage moléculaire
EP2694709B1 (fr) 2011-04-08 2016-09-14 Prognosys Biosciences, Inc. Constructions peptidiques et systèmes d'essai
CN110016499B (zh) 2011-04-15 2023-11-14 约翰·霍普金斯大学 安全测序系统
AU2012253366A1 (en) 2011-05-11 2014-01-09 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
US9625469B2 (en) 2011-06-23 2017-04-18 Board Of Regents, The University Of Texas System Identifying peptides at the single molecule level
WO2013028788A1 (fr) 2011-08-22 2013-02-28 Exosome Diagnostics, Inc. Marqueurs biologiques d'urine
US20130052665A1 (en) 2011-08-25 2013-02-28 Bruce Xuefeng Ling Methods for diagnosis of systemic juvenile idiopathic arthritis
US9335292B2 (en) 2011-10-13 2016-05-10 Auburn University Electrochemical proximity assay
WO2013071239A1 (fr) 2011-11-10 2013-05-16 Exosome Diagnostics, Inc. Dosage du liquide céphalorachidien
US20150087526A1 (en) 2012-01-24 2015-03-26 The Regents Of The University Of Colorado, A Body Corporate Peptide identification and sequencing by single-molecule detection of peptides undergoing degradation
LT3363901T (lt) 2012-02-17 2021-04-12 Fred Hutchinson Cancer Research Center Kompozicijos ir būdai, skirti tiksliam mutacijų nustatymui
US9862995B2 (en) 2012-03-13 2018-01-09 Abhijit Ajit Patel Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing
HUE051845T2 (hu) 2012-03-20 2021-03-29 Univ Washington Through Its Center For Commercialization Módszerek a tömegesen párhuzamos DNS-szekvenálás hibaarányának csökkentésére duplex konszenzus szekvenálással
US9005888B2 (en) 2012-06-14 2015-04-14 System Biosciences, Llc Methods for microvesicle isolation and selective removal
NL2009191C2 (en) 2012-07-16 2014-01-20 Univ Delft Tech Single molecule protein sequencing.
US20140378322A1 (en) * 2012-08-14 2014-12-25 10X Technologies, Inc. Compositions and methods for sample processing
US20150376609A1 (en) 2014-06-26 2015-12-31 10X Genomics, Inc. Methods of Analyzing Nucleic Acids from Individual Cells or Cell Populations
US20140155295A1 (en) 2012-08-14 2014-06-05 10X Technologies, Inc. Capsule array devices and methods of use
WO2014039715A1 (fr) * 2012-09-07 2014-03-13 University Of Rochester Procédés et compositions pour le marquage spécifique d'un site de peptides et de protéines
WO2014055775A1 (fr) 2012-10-03 2014-04-10 Exosome Diagnostics, Inc. Utilisation de microvésicules dans le diagnostic, le pronostic et le traitement de maladies et d'états médicaux
CA2928520C (fr) 2012-10-23 2023-03-14 Caris Life Sciences Switzerland Holdings, S.A.R.L. Aptameres et leurs utilisations
US10767221B2 (en) * 2013-03-15 2020-09-08 Illumina, Inc. Enzyme-linked nucleotides
WO2014145123A2 (fr) * 2013-03-15 2014-09-18 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State Unversity Contrôle de qualité d'un réseau peptidique
WO2014144713A2 (fr) 2013-03-15 2014-09-18 Immumetrix, Inc. Méthode de séquençage du répertoire immunitaire
US9435810B2 (en) 2013-03-15 2016-09-06 Washington University Molecules and methods for iterative polypeptide analysis and processing
US10053725B2 (en) 2013-04-23 2018-08-21 President And Fellows Of Harvard College In situ interaction determination
US10011830B2 (en) * 2013-05-19 2018-07-03 The Board of Trustee of theLeland Stanford junior University Devices and methods for display of encoded peptides, polypeptides, and proteins on DNA
DK3013984T3 (da) 2013-06-25 2023-06-06 Prognosys Biosciences Inc Metode til bestemmelse af spatiale mønstre i biologiske targets i en prøve
US10876177B2 (en) * 2013-07-10 2020-12-29 President And Fellows Of Harvard College Compositions and methods relating to nucleic acid-protein complexes
JP2016533752A (ja) 2013-08-28 2016-11-04 カリス ライフ サイエンシズ スウィッツァーランド ホー オリゴヌクレオチドプローブおよびその使用
WO2015042506A1 (fr) 2013-09-23 2015-03-26 The Trustees Of Columbia University In The City Of New York Identification à haut débit de protéines moléculaires individuelles
US10288608B2 (en) 2013-11-08 2019-05-14 Prognosys Biosciences, Inc. Polynucleotide conjugates and methods for analyte detection
US9834814B2 (en) * 2013-11-22 2017-12-05 Agilent Technologies, Inc. Spatial molecular barcoding of in situ nucleic acids
NZ723336A (en) 2014-02-27 2017-04-28 Univ Texas Methods and compositions for isolating exosomes
US10858698B2 (en) 2014-03-25 2020-12-08 President And Fellows Of Harvard College Barcoded protein array for multiplex single-molecule interaction profiling
CA2946144A1 (fr) 2014-04-21 2015-10-29 President And Fellows Of Harvard College Systemes et procedes permettant de marquer des acides nucleiques avec un code a barres
US10590407B2 (en) * 2014-04-24 2020-03-17 Nanyang Technological University Asx-specific protein ligase
WO2015166768A1 (fr) 2014-05-02 2015-11-05 国立大学法人金沢大学 Procédé d'analyse d'un acide nucléique dérivé d'une cellule unique
WO2015176034A1 (fr) 2014-05-15 2015-11-19 Two Pore Guys, Inc. Stockage de données de structure et détection de cible dans un échantillon au moyen d'un nanopore
AU2015279617A1 (en) 2014-06-26 2017-01-12 10X Genomics, Inc. Analysis of nucleic acid sequences
WO2016004068A1 (fr) * 2014-06-30 2016-01-07 Jae-Won Shin Compositions d'hydrogel comportant des cellules encapsulées et leurs méthodes d'utilisation
CA3084920C (fr) 2014-07-09 2023-02-28 Exosome Diagnostics, Inc. Procedes pour isoler des microvesicules et extraire des acides nucleiques a partir d'echantillons biologiques
WO2016011364A1 (fr) 2014-07-18 2016-01-21 Cdi Laboratories, Inc. Procédés et compositions pour identifier, quantifier, et caractériser des analytes cibles et des fragments de liaison
WO2016019360A1 (fr) * 2014-08-01 2016-02-04 Dovetail Genomics Llc Marquage d'acides nucléiques pour l'assemblage de séquences
US10545153B2 (en) 2014-09-15 2020-01-28 Board Of Regents, The University Of Texas System Single molecule peptide sequencing
RU2709655C2 (ru) 2014-10-17 2019-12-19 Иллумина Кембридж Лимитед Транспозиция с сохранением сцепления генов
US9771412B2 (en) * 2014-10-31 2017-09-26 Wisconsin Alumni Research Foundation Engineered intein for improved production of protein-intein fusions
KR20200020997A (ko) 2015-02-10 2020-02-26 일루미나, 인코포레이티드 세포 성분을 분석하기 위한 방법 및 조성물
EP3262192B1 (fr) 2015-02-27 2020-09-16 Becton, Dickinson and Company Codage à barres moléculaire à adressage spatial
US20180284125A1 (en) 2015-03-11 2018-10-04 The Broad Institute, Inc. Proteomic analysis with nucleic acid identifiers
WO2016164530A1 (fr) 2015-04-07 2016-10-13 University Of Maryland, College Park Compositions et procédés pour le séquençage de protéines à haut débit
WO2016201064A1 (fr) 2015-06-09 2016-12-15 The Board Of Regents Of The University Of Texas System Test de diagnostic pour le cancer à un stade précoce
EP3397764A4 (fr) 2015-12-30 2019-05-22 Bio-Rad Laboratories, Inc. Quantification numérique de protéines
US11286517B2 (en) 2016-02-17 2022-03-29 President And Fellows Of Harvard College Molecular programming tools
CN110199019B (zh) 2016-05-02 2024-09-10 Encodia有限公司 采用核酸编码的大分子分析
US11208676B2 (en) 2016-05-27 2021-12-28 President And Fellows Of Harvard College Conditional primer extension for single-molecule detection
WO2018005720A1 (fr) 2016-06-30 2018-01-04 President And Fellows Of Harvard College Procédé de détermination de la liaison moléculaire entre des banques de molécules
EP3488018A4 (fr) 2016-07-22 2020-02-12 President and Fellows of Harvard College Procédés et compositions pour l'identification de protéines
WO2018140966A1 (fr) 2017-01-30 2018-08-02 10X Genomics, Inc. Procédés et systèmes de codage à barres de cellules individuelles sur la base de gouttelettes
FI3583214T3 (fi) 2017-02-02 2023-12-19 New York Genome Center Inc Menetelmiä ja koostumuksia biologisen näytteen sisältämien kohteiden tunnistamiseksi tai kvantifioimiseksi
EP3704249A4 (fr) 2017-10-31 2021-10-27 Encodia, Inc. Kits d'analyse utilisant un codage et/ou une étiquette d'acide nucléique
US20200348307A1 (en) 2017-10-31 2020-11-05 Encodia, Inc. Methods and compositions for polypeptide analysis
WO2019089851A1 (fr) 2017-10-31 2019-05-09 Encodia, Inc. Procédés et kits faisant appel au codage et/ou au marquage par acides nucléiques
MX2020006803A (es) 2017-12-29 2020-10-28 Nautilus Biotechnology Inc Estrategias de descodificacion para identificacion de proteinas.
WO2019144056A1 (fr) 2018-01-18 2019-07-25 Nanosomix, Inc. Détection d'exosomes et de biomarqueurs exosomaux pour le diagnostic et le pronostic de maladies et de troubles
US20190301985A1 (en) 2018-04-03 2019-10-03 Tymora Analytical Operations, Inc. Methods for affinity-based non-antibody capture and purification of extracellular vesicles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090264300A1 (en) * 2005-12-01 2009-10-22 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
WO2009050261A1 (fr) * 2007-10-19 2009-04-23 Pronota N.V. Préparation d'échantillons pour une analyse protéomique
US20110245111A1 (en) * 2010-04-05 2011-10-06 Prognosys Biosciences, Inc. Spatially encoded biological assays

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MELKKO ET AL: "Lead discovery by DNA-encoded chemical libraries", DRUG DISCOVERY TODAY, ELSEVIER, AMSTERDAM, NL, vol. 12, no. 11-12, 1 June 2007 (2007-06-01), pages 465 - 471, XP022095609, ISSN: 1359-6446, DOI: 10.1016/J.DRUDIS.2007.04.007 *

Also Published As

Publication number Publication date
WO2017192633A1 (fr) 2017-11-09
JP2019523635A (ja) 2019-08-29
US20240302381A1 (en) 2024-09-12
JP2022065157A (ja) 2022-04-26
WO2017192633A9 (fr) 2017-12-14
NZ747941A (en) 2023-04-28
US20190145982A1 (en) 2019-05-16
KR102379048B1 (ko) 2022-03-28
EP4299803A2 (fr) 2024-01-03
SG11201809649WA (en) 2018-11-29
JP7097627B2 (ja) 2022-07-08
US20240302382A1 (en) 2024-09-12
JP2020120682A (ja) 2020-08-13
EP3452591B1 (fr) 2023-08-16
JP7120630B2 (ja) 2022-08-17
US12019077B2 (en) 2024-06-25
AU2017259794A1 (en) 2018-11-22
US11959922B2 (en) 2024-04-16
DK3452591T5 (da) 2024-09-09
CN110199019A (zh) 2019-09-03
JP2022126865A (ja) 2022-08-30
EP4299803A3 (fr) 2024-03-27
US20240125792A1 (en) 2024-04-18
KR102516168B1 (ko) 2023-03-30
KR20190035613A (ko) 2019-04-03
KR20220038549A (ko) 2022-03-28
US20230054691A1 (en) 2023-02-23
JP7333975B2 (ja) 2023-08-28
US20240295563A1 (en) 2024-09-05
KR20230047506A (ko) 2023-04-07
EP3452591A1 (fr) 2019-03-13
US12019078B2 (en) 2024-06-25
DK3452591T3 (da) 2023-09-18
MX2018013341A (es) 2019-09-18
CA3022863A1 (fr) 2017-11-09
AU2017259794B2 (en) 2023-04-13
CN110199019B (zh) 2024-09-10
US20210302431A1 (en) 2021-09-30
JP2024041969A (ja) 2024-03-27
US20210405058A1 (en) 2021-12-30
SG10201911917WA (en) 2020-01-30

Similar Documents

Publication Publication Date Title
EP3452591A4 (fr) Analyse de macromolécules au moyen du codage par acides nucléiques
EP3472359A4 (fr) Séquençage d'acide nucléique
EP3433382A4 (fr) Spike-ins d'acides nucléiques synthétiques
EP3559231A4 (fr) Procédés pour le traitement d'échantillons d'acides nucléiques
EP3409780A4 (fr) Complexe d'acides nucléiques
EP3516082A4 (fr) Système de préparation d'acides nucléiques
EP3253910A4 (fr) Amplification d'acides nucléiques en émulsions multiples
EP3161162A4 (fr) Analyse de séquences d'acides nucléiques
EP3252468A4 (fr) Système de mesure d'informations biologiques
EP3169793A4 (fr) Procédés isothermes pour l'amplification d'échantillons d'acide nucléique
EP3372693A4 (fr) Procédé de préparation d'échantillon d'acide nucléique
EP3134550A4 (fr) Détermination de structure à haut rendement à l'aide de calibres d'acides nucléiques
EP3497242A4 (fr) Méthodes d'analyse de fragments d'acides nucléiques
EP3512947A4 (fr) Procédés de préparation d'échantillon d'acide nucléique
EP3318876A4 (fr) Boîte de réaction d'échantillon biologique
EP3209777A4 (fr) Méthodes d'assemblage d'acides nucléiques
EP3279669A4 (fr) Système d'analyse de type modulaire
GB201403216D0 (en) Nucleic acid sample preparation
EP3366773A4 (fr) Complexe d'acides nucléiques
EP3498724A4 (fr) Complexe d'acides nucléiques
EP3158088A4 (fr) Préparation d'échantillons d'acide nucléique
EP3841218B8 (fr) Procédés de détection reposant sur un acide nucléique
EP3303574A4 (fr) Biocapteur électrochimique
GB201413318D0 (en) Nucleic acid sample preparation
GB201418621D0 (en) Improved nucleic acid sample preparation using concatenation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20191107

RIC1 Information provided on ipc code assigned before grant

Ipc: C40B 20/04 20060101ALI20191031BHEP

Ipc: C12N 15/10 20060101AFI20191031BHEP

Ipc: C40B 40/04 20060101ALI20191031BHEP

Ipc: C40B 70/00 20060101ALI20191031BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1261449

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210514

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ENCODIA, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230227

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230612

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ENCODIA, INC.

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017072834

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20230911

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1600102

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230816

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231216

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231218

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231116

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231216

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231117

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017072834

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20240526

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240527

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240530

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20240527

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20240602

Year of fee payment: 8

26N No opposition filed

Effective date: 20240517

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230816

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240527

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20240527

Year of fee payment: 8

Ref country code: BE

Payment date: 20240527

Year of fee payment: 8

REG Reference to a national code

Ref country code: DK

Ref legal event code: T5

Effective date: 20240903